Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Merck
Farmers Insurance
Baxter
Argus Health
US Department of Justice

Generated: August 25, 2019

DrugPatentWatch Database Preview

Patent: 9,133,518

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,133,518
Title:Method for determining predisposition to pulmonary infection
Abstract: Provided herein are methods and materials for diagnosing a subject\'s predisposition for pulmonary infection in a CF subject by detecting a pulmonary infection genetic marker. Pulmonary infection markers have been identified in the IL-1 gene cluster and may be useful in predicting CF disease progression and assessing a CF subject\'s response to therapy.
Inventor(s): Levy; Hara (Bayside, WI), Gerard; Craig (Chestnut Hill, MA), Pier; Gerald (Brookline, MA), Weiss; Scott (Chestnut Hill, MA), Lange; Christoph (Cambridge, MA)
Assignee: Presidental and Fellows of Harvard College (Cambridge, MA)
Application Number:13/296,557
Patent Claims:see list of patent claims

Details for Patent 9,133,518

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27   Try a Free Trial Presidental and Fellows of Harvard College (Cambridge, MA) 2027-04-27 RX Orphan search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 003 2001-11-14   Try a Free Trial Presidental and Fellows of Harvard College (Cambridge, MA) 2027-04-27 RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 002 2001-11-14   Try a Free Trial Presidental and Fellows of Harvard College (Cambridge, MA) 2027-04-27 RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 001 2001-11-14   Try a Free Trial Presidental and Fellows of Harvard College (Cambridge, MA) 2027-04-27 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Moodys
Chubb
Citi
Accenture
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.